HOME >> MEDICINE >> NEWS
Heart disease in women worse than previously thought

Angina, a common form of heart disease, is more dangerous for women than was previously thought, according to a new study published in the Journal of the American Medical Association (JAMA). The collaborative study, led by UCL (University College London) and funded by the British Heart Foundation, found that angina in women is as common as it is in men, in contrast to heart attacks (myocardial infarction) which have a higher rate in men. The findings suggest that the medical profession should pay more attention to thoroughly investigating and diagnosing women suspected of having angina.

UCL Professor Harry Hemingway and colleagues studied over 100,000 patients aged 45-89 years with angina using electronic health records. They found that each year, two women out of every 100 in the general population developed angina, as the first sign of heart disease. This makes angina much more common than heart attacks (the risks of which are usually measured per 1,000 population).

The study also found that for women, the diagnosis of angina is less frequently confirmed with tests, such as angiograms or treadmill exercise electrocardiograms. In the patients in the study, drug treatment aimed at relieving angina (nitrates) was prescribed solely on the basis of symptom history.

In the study, angina in women was also associated with increased death rates, where women diagnosed without the confirmatory test had significantly higher death rates from heart disease. Such women have often been dismissed as having a 'soft' subjective complaint, without real pathological changes in the heart. The study suggests that this attitude is incorrect.

Among women with angina and diabetes, the annual risk of a heart attack was particularly high and similar to the risk in men (about one in 10).

Professor Hemingway, from the UCL Department of Epidemiology and Public Health, says: "For women, angina is a more significant public health problem than many
'"/>

Contact: Jenny Gimpel
j.gimpel@ucl.ac.uk
44-207-679-9739
University College London
21-Mar-2006


Page: 1 2

Related medicine news :

1. Drug-eluting stent controversy explored in the American Heart Hospital Journal
2. Heart-failure patients benefit from pharmacist care
3. Study offers clues to Broken Heart Syndrome
4. Heart Failure 2007
5. Heart failure medication does not improve survival, compared to more widely used medication
6. UCLA neurologist honored with American Heart Associations Stroke Council Award
7. Heart failure: Mayo Clinic reveals abnormality in filling of the heart is frequent culprit
8. Heart catheters do not benefit patients
9. Heart Rhythm Society publishes final recommendations for heart patients
10. Heartburn drug may help to slow progression of chronic heart failure
11. Heart failure drugs may be beneficial for patients with hardening of the arteries

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Heart disease women worse than previously thought

(Date:5/25/2013)... York (PRWEB) May 25, 2013 ... litigation underway in U.S. District Court, Western District of ... According to a Case Management Order issued on ... the filing of contested motions in the Actos bladder ... motions. (In re: Actos Product Liability Litigation, MDL No. ...
(Date:5/25/2013)... The report “Global Food Encapsulation Market (2012 – ... Materials, Packaging, & Geography: Trends & Forecasts” defines ... analysis and forecasting of the global revenue for ... restraining factors for the global food encapsulation markets ... market is segmented and revenue are forecasted on ...
(Date:5/25/2013)... 25, 2013 Providing patients with their best ... team of weight management professionals. But, aside from educating patients ... Diet Doc’s hCG diets also provide patients, who ... childhood like bullying, more control over their lives by achieving ... with the underlying factors of weight gain derived from earlier ...
(Date:5/25/2013)... New York, New York (PRWEB) May 25, 2013 ... patients who allegedly suffered serious, life-threatening episodes of internal bleeding ... federal litigation underway in U.S. District Court, Southern District of ... on the Court’s website, 818 Pradaxa side effect claims had ... 24, 2013. That’s up from 705 claims reported by ...
(Date:5/25/2013)... New York, NY (PRWEB) May 25, 2013 ... organization dedicated to brain cancer research and advocacy, comments ... for Extraterrestrial Physics, that shows incorporating cold atmospheric plasma ... glioblastoma cells. , According to a Science ... for Extraterrestrial Physics (MPE), biologists and physicians demonstrated the ...
Breaking Medicine News(10 mins):Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 3Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 2Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 3Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 2Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 3Health News:Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells 2
(Date:5/23/2013)... , May 23, 2013 Nephros, Inc. ... stage medical device company that develops and sells high ... of its rights offering.  In addition, the concurrent temporary ... warrants expired on May 17, 2013. Nephros ... million from the rights offering.   A portion of the ...
(Date:5/23/2013)... -- Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a ... intellectual property developed and owned by Hadassah University ... research center, today announced that its portfolio company, ... the Israeli Ministry of Industry and Commerce, Office ... development and advance clinical trials. Cell Cure,s development ...
(Date:5/23/2013)... 2013  Texas, premier physician associations today announced the ... tools they need to provide demonstrably better and more ... marketplace. "I am confident the Physician Services ... Stephen L. Brotherton , MD, president ... doctors are determined to make health care ...
Breaking Medicine Technology:Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2TMA Launches Physician Services Organization for Patient Care 2TMA Launches Physician Services Organization for Patient Care 3TMA Launches Physician Services Organization for Patient Care 4
Cached News: